Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomized, Double-blind, Multicenter, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 in Combination With Docetaxel (TAXOTERE™) in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-based Chemotherapy.
Vandetanib, Docetaxel
D4200C00006
NCT00047840
Non-Small Cell Lung Cancer
Phase 2
 
Datasets and document are available as per Sanofi Policy and criteria
May 2017

Powered by ideaPoint, Inc.